9
answers
0
watching
737
views
1 Jan 2018
Consider a hypothetical bacterial operon encoding genes needed for the degradation of compound X. Which statement is most likely to be true? I know the answer is B when X is abundant, the operon is on. But why is this? An explanation would be helpful.
A. when X is abundant, the operon is off B. when X is abundant, the operon is on C. this operon displays repressible, rather than inducible, expression.
D. the mRNA produced by this operon is monocistronic
Consider a hypothetical bacterial operon encoding genes needed for the degradation of compound X. Which statement is most likely to be true? I know the answer is B when X is abundant, the operon is on. But why is this? An explanation would be helpful.
A. when X is abundant, the operon is off B. when X is abundant, the operon is on C. this operon displays repressible, rather than inducible, expression.
D. the mRNA produced by this operon is monocistronic
9
answers
0
watching
737
views
For unlimited access to Homework Help, a Homework+ subscription is required.
iloveyou2023Lv10
24 Nov 2023
experttutorLv10
25 Nov 2022
Already have an account? Log in
christopherc63Lv10
15 Nov 2022
Already have an account? Log in
gloryolalere280Lv10
15 Nov 2022
Already have an account? Log in
glorysoft2Lv10
25 Sep 2022
Already have an account? Log in
Tod ThielLv2
4 Jan 2018
Already have an account? Log in
Related textbook solutions
Related questions
Mutations that introduce stop codons cause a number of geneticdiseases. For example, from 2% to 5% of the people who have cysticfibrosis possess a mutation that causes a premature stop codon inthe gene encoding the cystic fibrosis transmembrane conductanceregulator (CFTR). This premature stop codon produces a truncatedform of CFTR that is nonfunctional and results in the symptoms ofcystic fibrosis. One possible way to treat people with geneticdiseases caused by these types of mutations is to trick theribosome into reading through the stop codon, inserting an aminoacid into its place. Although the protein produced may have onealtered amino acid, it is more likely to be at least partlyfunctional than is the truncated protein produced when the ribosomestalls at the stop codon. Indeed, geneticists have conductedclinical trials on people with cystic fibrosis with the use of adrug called PTC124, which interferes with the ribosome's ability tocorrectly read stop codons (C. Ainsworth, 2005, Nature438:726รขยย728). On the basis of what you know about the mechanism ofnonsense-mediated mRNA decay (NMD), would you expect NMD to be aproblem with this type of treatment? | |||||||||||
|